Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE10.8000
- TODAY'S CHANGE (%)0.0600 (0.5587%)
- Bid / Lots10.9100/ 1
- Ask / Lots11.0400/ 8
- Open / Previous Close10.7700 / 10.7400
- Day Range
- 52 Week Range
- Volume3,579,769
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 19163 | 10.77 |
| 09:34 ET | 2000 | 10.79 |
| 09:36 ET | 9263 | 10.83 |
| 09:38 ET | 2023 | 10.885 |
| 09:39 ET | 8486 | 10.86 |
| 09:41 ET | 2884 | 10.87 |
| 09:43 ET | 16404 | 10.92 |
| 09:45 ET | 15188 | 10.97 |
| 09:48 ET | 9062 | 10.99 |
| 09:50 ET | 26709 | 11.05 |
| 09:52 ET | 15523 | 11.025 |
| 09:54 ET | 43334 | 11.02 |
| 09:56 ET | 19805 | 11.01 |
| 09:57 ET | 15836 | 10.98 |
| 09:59 ET | 21001 | 10.96 |
| 10:01 ET | 11197 | 10.94 |
| 10:03 ET | 10253 | 10.96 |
| 10:06 ET | 6022 | 10.97 |
| 10:08 ET | 57543 | 10.99 |
| 10:10 ET | 5983 | 10.945 |
| 10:12 ET | 9139 | 10.95 |
| 10:14 ET | 10943 | 10.92 |
| 10:15 ET | 3200 | 10.905 |
| 10:17 ET | 6259 | 10.925 |
| 10:19 ET | 2000 | 10.91 |
| 10:21 ET | 2971 | 10.92 |
| 10:24 ET | 4167 | 10.915 |
| 10:26 ET | 7708 | 10.905 |
| 10:28 ET | 4197 | 10.915 |
| 10:30 ET | 6877 | 10.905 |
| 10:32 ET | 34598 | 10.88 |
| 10:33 ET | 11307 | 10.87 |
| 10:35 ET | 1600 | 10.875 |
| 10:37 ET | 3505 | 10.88 |
| 10:39 ET | 7662 | 10.885 |
| 10:42 ET | 1100 | 10.885 |
| 10:44 ET | 18065 | 10.87 |
| 10:46 ET | 3960 | 10.85 |
| 10:48 ET | 9210 | 10.855 |
| 10:50 ET | 14458 | 10.845 |
| 10:51 ET | 5950 | 10.835 |
| 10:53 ET | 5957 | 10.84 |
| 10:55 ET | 2319 | 10.845 |
| 10:57 ET | 12758 | 10.86 |
| 11:00 ET | 16311 | 10.85 |
| 11:02 ET | 9651 | 10.855 |
| 11:04 ET | 2534 | 10.845 |
| 11:06 ET | 5982 | 10.845 |
| 11:08 ET | 26849 | 10.835 |
| 11:09 ET | 5598 | 10.84 |
| 11:11 ET | 5186 | 10.84 |
| 11:13 ET | 3944 | 10.835 |
| 11:15 ET | 4599 | 10.825 |
| 11:18 ET | 12001 | 10.83 |
| 11:20 ET | 8551 | 10.815 |
| 11:22 ET | 4823 | 10.84 |
| 11:24 ET | 2829 | 10.855 |
| 11:26 ET | 5810 | 10.86 |
| 11:27 ET | 1700 | 10.855 |
| 11:29 ET | 1821 | 10.855 |
| 11:31 ET | 18829 | 10.855 |
| 11:33 ET | 2300 | 10.85 |
| 11:36 ET | 5597 | 10.835 |
| 11:38 ET | 5403 | 10.86 |
| 11:40 ET | 16218 | 10.865 |
| 11:42 ET | 6869 | 10.875 |
| 11:44 ET | 6321 | 10.875 |
| 11:45 ET | 3269 | 10.875 |
| 11:47 ET | 18277 | 10.865 |
| 11:49 ET | 18801 | 10.835 |
| 11:51 ET | 3026 | 10.83 |
| 11:54 ET | 5876 | 10.845 |
| 11:56 ET | 6290 | 10.825 |
| 11:58 ET | 3558 | 10.83 |
| 12:00 ET | 5602 | 10.84 |
| 12:02 ET | 6307 | 10.845 |
| 12:03 ET | 10078 | 10.845 |
| 12:05 ET | 54380 | 10.85 |
| 12:07 ET | 8147 | 10.83 |
| 12:09 ET | 8868 | 10.8475 |
| 12:12 ET | 3994 | 10.835 |
| 12:14 ET | 5183 | 10.81 |
| 12:16 ET | 8212 | 10.815 |
| 12:18 ET | 3982 | 10.83 |
| 12:20 ET | 2377 | 10.826 |
| 12:21 ET | 7633 | 10.825 |
| 12:23 ET | 17120 | 10.795 |
| 12:25 ET | 12213 | 10.785 |
| 12:27 ET | 6979 | 10.775 |
| 12:30 ET | 28409 | 10.785 |
| 12:32 ET | 7977 | 10.77 |
| 12:34 ET | 5588 | 10.77 |
| 12:36 ET | 8506 | 10.7755 |
| 12:38 ET | 5789 | 10.785 |
| 12:39 ET | 5383 | 10.795 |
| 12:41 ET | 3141 | 10.795 |
| 12:43 ET | 10066 | 10.825 |
| 12:45 ET | 1775 | 10.83 |
| 12:48 ET | 3503 | 10.824 |
| 12:50 ET | 21501 | 10.815 |
| 12:52 ET | 4746 | 10.82 |
| 12:54 ET | 7634 | 10.8267 |
| 12:56 ET | 6862 | 10.825 |
| 12:57 ET | 1599 | 10.825 |
| 12:59 ET | 3426 | 10.826 |
| 01:01 ET | 3312 | 10.83 |
| 01:03 ET | 8753 | 10.82 |
| 01:06 ET | 11904 | 10.835 |
| 01:08 ET | 11103 | 10.815 |
| 01:10 ET | 1800 | 10.82 |
| 01:12 ET | 6721 | 10.825 |
| 01:14 ET | 3752 | 10.825 |
| 01:15 ET | 5527 | 10.815 |
| 01:17 ET | 6075 | 10.82 |
| 01:19 ET | 1411 | 10.825 |
| 01:21 ET | 2196 | 10.825 |
| 01:24 ET | 9336 | 10.825 |
| 01:26 ET | 3721 | 10.845 |
| 01:28 ET | 2100 | 10.845 |
| 01:30 ET | 1936 | 10.845 |
| 01:32 ET | 14721 | 10.845 |
| 01:33 ET | 14389 | 10.835 |
| 01:35 ET | 12063 | 10.82 |
| 01:37 ET | 3191 | 10.825 |
| 01:39 ET | 3234 | 10.83 |
| 01:42 ET | 8512 | 10.84 |
| 01:44 ET | 2100 | 10.84 |
| 01:46 ET | 4132 | 10.86 |
| 01:48 ET | 14227 | 10.855 |
| 01:50 ET | 8528 | 10.845 |
| 01:51 ET | 9223 | 10.84 |
| 01:53 ET | 4435 | 10.85 |
| 01:55 ET | 2345 | 10.855 |
| 01:57 ET | 1733 | 10.855 |
| 02:00 ET | 2112 | 10.85 |
| 02:02 ET | 8911 | 10.85 |
| 02:04 ET | 49543 | 10.85 |
| 02:06 ET | 9897 | 10.835 |
| 02:08 ET | 39634 | 10.85 |
| 02:09 ET | 15948 | 10.85 |
| 02:11 ET | 4233 | 10.845 |
| 02:13 ET | 7701 | 10.845 |
| 02:15 ET | 2818 | 10.85 |
| 02:18 ET | 10341 | 10.845 |
| 02:20 ET | 9542 | 10.835 |
| 02:22 ET | 3438 | 10.84 |
| 02:24 ET | 2799 | 10.835 |
| 02:26 ET | 5911 | 10.84 |
| 02:27 ET | 9055 | 10.825 |
| 02:29 ET | 19264 | 10.815 |
| 02:31 ET | 47847 | 10.805 |
| 02:33 ET | 21811 | 10.79 |
| 02:36 ET | 11516 | 10.805 |
| 02:38 ET | 4397 | 10.8 |
| 02:40 ET | 1529 | 10.805 |
| 02:42 ET | 11595 | 10.795 |
| 02:44 ET | 13752 | 10.8 |
| 02:45 ET | 737 | 10.8 |
| 02:47 ET | 12699 | 10.8 |
| 02:49 ET | 6971 | 10.795 |
| 02:51 ET | 20019 | 10.805 |
| 02:54 ET | 14922 | 10.795 |
| 02:56 ET | 2746 | 10.795 |
| 02:58 ET | 8973 | 10.795 |
| 03:00 ET | 51778 | 10.8 |
| 03:02 ET | 10374 | 10.795 |
| 03:03 ET | 10389 | 10.79 |
| 03:05 ET | 7519 | 10.78 |
| 03:07 ET | 6293 | 10.785 |
| 03:09 ET | 18252 | 10.795 |
| 03:12 ET | 11186 | 10.795 |
| 03:14 ET | 5322 | 10.8 |
| 03:16 ET | 36086 | 10.785 |
| 03:18 ET | 19761 | 10.78 |
| 03:20 ET | 6500 | 10.785 |
| 03:21 ET | 8922 | 10.795 |
| 03:23 ET | 6008 | 10.795 |
| 03:25 ET | 25133 | 10.79 |
| 03:27 ET | 16743 | 10.79 |
| 03:30 ET | 2572 | 10.8 |
| 03:32 ET | 49798 | 10.79 |
| 03:34 ET | 11161 | 10.785 |
| 03:36 ET | 12990 | 10.775 |
| 03:38 ET | 6269 | 10.77 |
| 03:39 ET | 6765 | 10.775 |
| 03:41 ET | 16738 | 10.785 |
| 03:43 ET | 8310 | 10.785 |
| 03:45 ET | 6270 | 10.785 |
| 03:48 ET | 17275 | 10.78 |
| 03:50 ET | 24709 | 10.775 |
| 03:52 ET | 98001 | 10.785 |
| 03:54 ET | 25038 | 10.79 |
| 03:56 ET | 59806 | 10.785 |
| 03:57 ET | 158318 | 10.8 |
| 03:59 ET | 348676 | 10.8 |
Yesterday
Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024, from 4:05PM ET on Thursday Jul 25, 2024 by Dow Jones
4:05PM ET on Thursday Jul 25, 2024 by Dow Jones
Jul 22, 2024
DJ S&P 500 Futures Climb In Premarket Trading; Neurocrine Biosciences, Equitable Holdings Lead, from 7:30AM ET on Monday Jul 22, 2024 by Dow Jones
7:30AM ET on Monday Jul 22, 2024 by Dow Jones
Jul 10, 2024
DJ Roivant Sciences Is Maintained at Overweight by Piper Sandler, from 10:20AM ET on Wednesday Jul 10, 2024 by Dow Jones
10:20AM ET on Wednesday Jul 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 7.9B | 2.1x | --- |
Ligand Pharmaceuticals Inc | 1.9B | 20.5x | -12.71% |
Corcept Therapeutics Inc | 3.6B | 33.3x | +9.80% |
Immunocore Holdings PLC | 2.0B | -33.4x | --- |
Avadel Pharmaceuticals PLC | 1.6B | -9.0x | --- |
Ocular Therapeutix Inc | 1.3B | -7.7x | --- |
Company Information
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immunology and includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; batoclimab and IMVT-1402, fully human monoclonal antibodies targeting the neonatal Fc receptor in development across several IgG-mediated autoimmune indications; and brepocitinib, a TYK2/JAK1 inhibitor in late stage development for dermatomyositis, non-infectious uveitis, and other autoimmune conditions, in addition to other clinical-stage molecules. It advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Contact Information
- Headquarters
- 11-12 St. James's Square Suite 1, 3rd FloorLONDON, United Kingdom SW1Y4LB
- Phone
- 207-400-3347
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ilan Oren
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer
- Mayukh Sukhatme
- Chief Executive Officer, Director
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.9B |
|---|---|
Revenue (TTM) | $124.8M |
Shares Outstanding | 738.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.24 |
EPS | $5.07 |
Book Value | $7.40 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | 63.6 |
Price/Cash Flow (TTM) | 1.9x |
Operating Margin | 3,425.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
